Nubia Muñoz is a Colombian medical scientist and epidemiologist, whose research has been instrumental in establishing that human papillomavirus (HPV) infection is the primary cause of cervical cancer which has led to the development of a vaccine that is capable of preventing 70% of all cervical cancers.
She would be the only one of her siblings to go to university when she was accepted into the medical school at Universidad del Valle, specializing in Pathology.
[1] After graduating, she completed a fellowship at the National Cancer Institute in Bethesda, Maryland, USA with an emphasis in pathology and virology.
She then earned a Master's Degree in Public Health (Cancer Epidemiology) from Johns Hopkins University in Baltimore, Maryland, USA.
), McGill University[6] International Agency for Research on Cancer Medal of Honor[7] Canada Gairdner Global Health Award[8] Charles Rodolphe Brupbacher Prize for Cancer Research[9] 2008 International Epidemiological Association's Richard Doll Prize[10] 2018 Frontiers of Knowledge Award, Development Cooperation category[11][12][13] Rumored to have been nominated for the Nobel Prize in Physiology and Medicine in 2008[14]